Morimoto Y - Search Results

1

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma.

Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Kikuchi R, et al. Among authors: morimoto y. J Clin Med. 2019 Feb 20;8(2):263. doi: 10.3390/jcm8020263. J Clin Med. 2019. PMID: 30791546 Free PMC article.

2

Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.

Tamura R, Ohara K, Sasaki H, Morimoto Y, Yoshida K, Toda M. Tamura R, et al. Among authors: morimoto y. J Neurooncol. 2018 Jan;136(2):233-241. doi: 10.1007/s11060-017-2648-9. Epub 2017 Nov 29. J Neurooncol. 2018. PMID: 29188530

3

Preoperative Assessment of Pathologic Subtypes of Meningioma and Solitary Fibrous Tumor/Hemangiopericytoma Using Dynamic Computed Tomography: A Clinical Research Study.

Arai N, Mizutani K, Takahashi S, Morimoto Y, Akiyama T, Horiguchi T, Mami H, Yoshida K. Arai N, et al. Among authors: morimoto y. World Neurosurg. 2018 Jul;115:e676-e680. doi: 10.1016/j.wneu.2018.04.132. Epub 2018 Apr 27. World Neurosurg. 2018. PMID: 29709742

4

Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma.

Tamura R, Ohara K, Sasaki H, Morimoto Y, Kosugi K, Yoshida K, Toda M. Tamura R, et al. Among authors: morimoto y. World Neurosurg. 2018 Dec;120:e601-e610. doi: 10.1016/j.wneu.2018.08.133. Epub 2018 Aug 27. World Neurosurg. 2018. PMID: 30165233

5

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab.

Tamura R, Tanaka T, Ohara K, Miyake K, Morimoto Y, Yamamoto Y, Kanai R, Akasaki Y, Murayama Y, Tamiya T, Yoshida K, Sasaki H. Tamura R, et al. Among authors: morimoto y. Cancer Sci. 2019 Feb;110(2):499-508. doi: 10.1111/cas.13889. Epub 2018 Dec 21. Cancer Sci. 2019. PMID: 30467920 Free PMC article.

6

PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion.

Tamura R, Ohara K, Morimoto Y, Kosugi K, Oishi Y, Sato M, Yoshida K, Toda M. Tamura R, et al. Among authors: morimoto y. Endocr Pathol. 2019 Jun;30(2):81-89. doi: 10.1007/s12022-019-9573-8. Endocr Pathol. 2019. PMID: 30903445

7

Visualization of spatiotemporal dynamics of human glioma stem cell invasion.

Tamura R, Miyoshi H, Sampetrean O, Shinozaki M, Morimoto Y, Iwasawa C, Fukaya R, Mine Y, Masuda H, Maruyama T, Narita M, Saya H, Yoshida K, Okano H, Toda M. Tamura R, et al. Among authors: morimoto y. Mol Brain. 2019 May 6;12(1):45. doi: 10.1186/s13041-019-0462-3. Mol Brain. 2019. PMID: 31060588 Free PMC article.

8

Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors.

Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y, Yoshida K, Toda M. Sato M, et al. Among authors: morimoto y. J Clin Med. 2019 May 16;8(5):695. doi: 10.3390/jcm8050695. J Clin Med. 2019. PMID: 31100921 Free PMC article.

9

Immunological and vascular characteristics in cavernous sinus meningioma.

Kosugi K, Tamura R, Ohara K, Morimoto Y, Kuranari Y, Oishi Y, Yoshida K, Toda M. Kosugi K, et al. Among authors: morimoto y. J Clin Neurosci. 2019 Sep;67:198-203. doi: 10.1016/j.jocn.2019.06.003. Epub 2019 Jun 15. J Clin Neurosci. 2019. PMID: 31213381

10

Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.

Morimoto Y, Tamura R, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Yoshida K, Toda M. Morimoto Y, et al. J Neurooncol. 2019 Aug;144(1):65-77. doi: 10.1007/s11060-019-03221-z. Epub 2019 Jun 25. J Neurooncol. 2019. PMID: 31240525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,425 results

Search Page

Filters